Kristin Nicole Damitz, OTD, OTR/L | |
3051 S Elm St, Denver, CO 80222-7339 | |
(720) 424-9468 | |
Not Available |
Full Name | Kristin Nicole Damitz |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 3051 S Elm St, Denver, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154888105 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT.0005847 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kristin Nicole Damitz, OTD, OTR/L 16363 E Fremont Ave Apt 717, Aurora, CO 80016-2245 Ph: (630) 303-2298 | Kristin Nicole Damitz, OTD, OTR/L 3051 S Elm St, Denver, CO 80222-7339 Ph: (720) 424-9468 |
News Archive
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
Transcept Pharmaceuticals, Inc. today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Intermezzo® for use as needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.
The first randomized controlled trial of scribes finds that they produce significant improvements in physician satisfaction without detracting from patient satisfaction.
Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail's FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva's generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.
› Verified 7 days ago
Kristin Turner, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3105 W Arkansas Ave, Denver, CO 80219 Phone: 303-936-3497 | |
American Council For Th Eblind And Visually Impaired Of Colorado Acbco Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 16th St Ste 1240, Denver, CO 80202 Phone: 303-831-0117 Fax: 303-454-3378 | |
Ana Nicole Miller, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2979 Uinta St, Denver, CO 80238 Phone: 720-787-7800 | |
Melanie Marie Shovlin, MS, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1460 S Saint Paul St, Denver, CO 80210 Phone: 303-550-5868 | |
Kristen Dorighi, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1667 S Lafayette St, Denver, CO 80210 Phone: 303-715-4482 | |
Sarah Whitaker, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6060 E Iliff Ave, Denver, CO 80222 Phone: 303-759-4221 | |
Julie Brahen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2201 N Downing St, Denver, CO 80205 Phone: 303-861-4825 |